Published : Jun-2018
No. of Pages : 92
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Vascular Grafts Overview 8
3 Products under Development 9
3.1 Vascular Grafts - Pipeline Products by Stage of Development 9
3.2 Vascular Grafts - Pipeline Products by Segment 10
3.3 Vascular Grafts - Pipeline Products by Territory 11
3.4 Vascular Grafts - Pipeline Products by Regulatory Path 12
3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date 13
3.6 Vascular Grafts - Ongoing Clinical Trials 14
4 Vascular Grafts - Pipeline Products under Development by Companies 15
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development 15
4.2 Vascular Grafts - Pipeline Products by Stage of Development 17
5 Vascular Grafts Companies and Product Overview 18
5.1 Ariste Medical LLC Company Overview 18
5.1.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 BioSurfaces, Inc. Company Overview 19
5.2.1 BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Cardiojustable LLC (Inactive) Company Overview 20
5.3.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Cardiovate Company Overview 21
5.4.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Colorado Therapeutics, LLC Company Overview 22
5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 CryoLife Inc Company Overview 23
5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 24
5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 DSM Biomedical BV Company Overview 26
5.8.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Eqalix Inc Company Overview 27
5.9.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 FIT Biotech Oy Company Overview 29
5.10.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Gel-Del Technologies, Inc. Company Overview 31
5.11.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Humacyte Inc Company Overview 32
5.12.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Innovia LLC Company Overview 36
5.13.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 LeMaitre Vascular Inc Company Overview 37
5.14.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 37
5.15 Merit Medical Systems Inc Company Overview 39
5.15.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Northwestern University Company Overview 40
5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 Peca Labs, Inc. Company Overview 41
5.17.1 Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 PetVivo Holdings Inc Company Overview 42
5.18.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.19 RegenaGraft Company Overview 43
5.19.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
5.20 Secant Group LLC Company Overview 44
5.20.1 Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview 44
5.21 Terumo Aortic Company Overview 45
5.21.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 45
5.22 TTK Healthcare Ltd Company Overview 46
5.22.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
5.23 Universidad de Los Andes Company Overview 47
5.23.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 47
5.24 University of Louisville Company Overview 48
5.24.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 48
5.25 University of Pittsburgh Company Overview 49
5.25.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 49
5.26 VA Boston Healthcare System Company Overview 50
5.26.1 VA Boston Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 50
5.27 VesselTek BioMedical LLC Company Overview 51
5.27.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 51
5.28 VESSL Therapeutics Ltd Company Overview 52
5.28.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
5.29 W. L. Gore & Associates Inc Company Overview 53
5.29.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.30 Xeltis AG Company Overview 56
5.30.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 56
6 Vascular Grafts- Recent Developments 57
6.1 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 57
6.2 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results 57
6.3 Apr 27, 2018: Fit Biotech: Appointment of Tommi Holopainen as CFO and as a Member of the Management Team 58
6.4 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 59
6.5 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) 61
6.6 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 61
6.7 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 63
6.8 Mar 15, 2018: FIT Biotech's Review of Operations and Financial Statement 2017 published 64
6.9 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 64
6.10 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017 65
6.11 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 66
6.12 Jan 23, 2018: Jonathan Vande Geest, University Of Pittsburg Has Received A NIH Grant To Construct A Biomeimetic, Small Diameter Vascular Graft 68
6.13 Jan 18, 2018: FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO 68
6.14 Jan 18, 2018: FIT Biotech Oy Announces Senior Management Changes 69
6.15 Jan 16, 2018: Secant Group Develops the First Synthetic Regenerative Cardiovascular Graft 69
6.16 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 70
6.17 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results 70
6.18 Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%) 72
6.19 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 72
6.20 Oct 25, 2017: Bard Announces Third Quarter Results 74
6.21 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 75
6.22 Oct 02, 2017: Humacyte Awarded $3.4 Million Contract Award from the U.S. Department of Defense 76
6.23 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors 76
6.24 Sep 26, 2017: ETR featured in peer-reviewed journal EuroIntervention 77
6.25 Sep 22, 2017: Xeltis CTO on the future of heart valve therapy at PCR London Valves 77
6.26 Sep 15, 2017: Fit Biotech Half-yearly Financial Report January 1 - June 30, 2017 78
6.27 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 78
6.28 Aug 23, 2017: FIT Biotech Oy: FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board 80
6.29 Aug 14, 2017: Governor McAuliffe Announces LifeNet Health to Invest $12.25 million, Create 321 New Jobs in City of Virginia Beach 80
6.30 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 81
6.31 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 81
6.32 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 82
6.33 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 84
6.34 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 84
6.35 Jul 20, 2017: Positive progression of ETR clinical trials at WCPCCS 86
6.36 Jul 07, 2017: MPSC New COO Glendy Wang on Board 86
6.37 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 86
7 Appendix 89
7.1 Methodology 89
7.2 About GlobalData 92
7.3 Contact Us 92
7.4 Disclaimer 92
1.1 List of Tables
Table 1: Vascular Grafts - Pipeline Products by Stage of Development 9
Table 2: Vascular Grafts - Pipeline Products by Segment 10
Table 3: Vascular Grafts - Pipeline Products by Territory 11
Table 4: Vascular Grafts - Pipeline Products by Regulatory Path 12
Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 13
Table 6: Vascular Grafts - Ongoing Clinical Trials 14
Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development 15
Table 8: Vascular Grafts - Pipeline Products by Stage of Development 17
Table 9: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 18
Table 10: Drug Eluting Vascular Graft - Product Status 18
Table 11: Drug Eluting Vascular Graft - Product Description 18
Table 12: BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 13: BioFunc - APC Vascular Graft - Product Status 19
Table 14: BioFunc - APC Vascular Graft - Product Description 19
Table 15: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 20
Table 16: Adjustable SPA Shunt - Product Status 20
Table 17: Adjustable SPA Shunt - Product Description 20
Table 18: Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 21
Table 19: NeoVessel Vascular Graft - Product Status 21
Table 20: NeoVessel Vascular Graft - Product Description 21
Table 21: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 22: Xenograft Implant - Peripheral Vascular Disease - Product Status 22
Table 23: Xenograft Implant - Peripheral Vascular Disease - Product Description 22
Table 24: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 25: Synergraft Xenograft Vascular Graft - Product Status 23
Table 26: Synergraft Xenograft Vascular Graft - Product Description 23
Table 27: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
Table 28: Lifeline TEBV - Lower Limb - Product Status 24
Table 29: Lifeline TEBV - Lower Limb - Product Description 24
Table 30: LifeLine TEBV - Pediatric - Product Status 25
Table 31: LifeLine TEBV - Pediatric - Product Description 25
Table 32: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 26
Table 33: Small Diameter Vascular Graft - Product Status 26
Table 34: Small Diameter Vascular Graft - Product Description 26
Table 35: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 36: CardioVessel - Product Status 27
Table 37: CardioVessel - Product Description 27
Table 38: LCL Graft - Product Status 28
Table 39: LCL Graft - Product Description 28
Table 40: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 29
Table 41: GTU X-Graft - Product Status 29
Table 42: GTU X-Graft - Product Description 29
Table 43: GTU X2-Graft - Product Status 30
Table 44: GTU X2-Graft - Product Description 30
Table 45: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 46: VasoGraft - Product Status 31
Table 47: VasoGraft - Product Description 31
Table 48: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 49: HUMACYL - Peripheral Artery Disease - Product Status 32
Table 50: HUMACYL - Peripheral Artery Disease - Product Description 32
Table 51: HUMACYL Graft - Vascular Trauma - Product Status 33
Table 52: HUMACYL Graft - Vascular Trauma - Product Description 33
Table 53: Humacyte Inc - Ongoing Clinical Trials Overview 34
Table 54: HUMACYL - Peripheral Artery Disease - A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Use as a Vascular Bypass or Interposition Vessel in Patients with Limb-threatening Peripheral Arterial Trauma 35
Table 55: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 36
Table 56: 4mm Vascular Graft - Product Status 36
Table 57: 4mm Vascular Graft - Product Description 36
Table 58: LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 59: LifeSpan ePTFE Vascular Graft - Product Status 37
Table 60: LifeSpan ePTFE Vascular Graft - Product Description 38
Table 61: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 62: Self-expanding Covered Stent Graft - Product Status 39
Table 63: Self-expanding Covered Stent Graft - Product Description 39
Table 64: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
Table 65: ePTFE Graft - Peripheral Arterial Disease - Product Status 40
Table 66: ePTFE Graft - Peripheral Arterial Disease - Product Description 40
Table 67: Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 68: exGraft - Product Status 41
Table 69: exGraft - Product Description 41
Table 70: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 71: Peripheral Vascular Graft - Product Status 42
Table 72: Peripheral Vascular Graft - Product Description 42
Table 73: RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
Table 74: RegenaVasc - Product Status 43
Table 75: RegenaVasc - Product Description 43
Table 76: Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview 44
Table 77: Regenerative Cardiovascular Graft - Product Status 44
Table 78: Regenerative Cardiovascular Graft - Product Description 44
Table 79: Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 45
Table 80: Triplex Advanced Vascular Graft - Product Status 45
Table 81: Triplex Advanced Vascular Graft - Product Description 45
Table 82: TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Table 83: Chitra Vascular Graft - Product Status 46
Table 84: Chitra Vascular Graft - Product Description 46
Table 85: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 47
Table 86: SiSgraft - Product Status 47
Table 87: SiSgraft - Product Description 47
Table 88: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 48
Table 89: Vascular Graft System - Product Status 48
Table 90: Vascular Graft System - Product Description 48
Table 91: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 49
Table 92: Biomimetic Vascular Graft - Product Status 49
Table 93: Biomimetic Vascular Graft - Product Description 49
Table 94: VA Boston Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 50
Table 95: SelfWrap - Product Status 50
Table 96: SelfWrap - Product Description 50
Table 97: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 51
Table 98: VTek Graft - Product Status 51
Table 99: VTek Graft - Product Description 51
Table 100: VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
Table 101: MultiGeneGraft - Product Status 52
Table 102: MultiGeneGraft - Product Description 52
Table 103: W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 104: GORE VIABAHN Endoprosthesis - Product Status 53
Table 105: GORE VIABAHN Endoprosthesis - Product Description 53
Table 106: W. L. Gore & Associates Inc - Ongoing Clinical Trials Overview 54
Table 107: GORE VIABAHN Endoprosthesis - Post-approval Study of the Gore Viabahn Endoprosthesis for the Treatment of In-stent Restenosis (ISR) in the Superficial Femoral Artery (SFA) 55
Table 108: GORE VIABAHN Endoprosthesis - Post-market Study: Evaluation of the GORE VIABAHN Endoprosthesis for the Treatment of Popliteal Artery Aneurysm 55
Table 109: GORE VIABAHN Endoprosthesis - The Utility of GP1101 Relative to Surgical Bypass in the Treatment of Femoral / Popliteal Arterial Symptomatic Peripheral Arterial Disease 55
Table 110: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 56
Table 111: Endogenous Tissue Restoration (ETR) Cardiovascular Graft - Product Status 56
Table 112: Endogenous Tissue Restoration (ETR) Cardiovascular Graft - Product Description 56
Table 113: Glossary 91
1.2 List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 9
Figure 2: Vascular Grafts - Pipeline Products by Segment 10
Figure 3: Vascular Grafts - Pipeline Products by Territory 11
Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path 12
Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 13
Figure 6: Vascular Grafts - Ongoing Clinical Trials 14
